Use of antenatal corticosteroids in the management of preterm delivery

dc.contributor.authorMsan, Anthony K.
dc.contributor.authorUsta, Ihab M.
dc.contributor.authorMirza, Fadi Ghazi
dc.contributor.authorNassar, Anwar H.
dc.contributor.departmentObstetrics and Gynecology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:07:58Z
dc.date.available2025-01-24T12:07:58Z
dc.date.issued2015
dc.description.abstractObjective This narrative review of the literature explores the current evidence and recommendations in favor of antenatal corticosteroids use during impending preterm deliveries as well as related issues and concerns. Study Design Synthesis of findings from published medical literature on antenatal corticosteroids and prematurity, retrieved from searches of computerized databases and authoritative texts. Results It is now recognized that an intramuscular course of betamethasone or dexamethasone given to a woman expected to deliver preterm not only accelerates pulmonary epithelial development but also matures other organ systems, significantly decreasing the chances of neonatal morbidities and increasing chances of survival. Conclusion There remain uncertainties over the efficacy of the established protocol in populations such as the very early preterm, the late preterm, and multiple gestations. Alternative regimens remain controversial because of fear of adverse effects and doubts regarding whether benefits outweigh risks. Copyright © 2015 by Thieme Medical Publishers, Inc.
dc.identifier.doihttps://doi.org/10.1055/s-0034-1395476
dc.identifier.eid2-s2.0-84927600992
dc.identifier.pmid25535931
dc.identifier.urihttp://hdl.handle.net/10938/31654
dc.language.isoen
dc.publisherThieme Medical Publishers, Inc.
dc.relation.ispartofAmerican Journal of Perinatology
dc.sourceScopus
dc.subjectAntenatal corticosteroids
dc.subjectBetamethasone
dc.subjectDexamethasone
dc.subjectPrematurity
dc.subjectFemale
dc.subjectFetal organ maturity
dc.subjectGestational age
dc.subjectGlucocorticoids
dc.subjectHumans
dc.subjectInfant, newborn
dc.subjectInfant, premature
dc.subjectPregnancy
dc.subjectPregnancy complications
dc.subjectPremature birth
dc.subjectRandomized controlled trials as topic
dc.subjectRespiratory distress syndrome, newborn
dc.subjectCorticosteroid
dc.subjectGlucocorticoid
dc.subjectCorticosteroid therapy
dc.subjectHuman
dc.subjectMultiple pregnancy
dc.subjectNewborn morbidity
dc.subjectPremature labor
dc.subjectPrenatal care
dc.subjectPriority journal
dc.subjectReview
dc.subjectDrug effects
dc.subjectFetus maturity
dc.subjectGrowth, development and aging
dc.subjectNewborn
dc.subjectRandomized controlled trial (topic)
dc.titleUse of antenatal corticosteroids in the management of preterm delivery
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2015-5060.pdf
Size:
202.96 KB
Format:
Adobe Portable Document Format